Browsing by Subject "cancer"
Now showing items 1-6 of 6
-
Bioinformatic Analysis to Identify and Understand Aberrant DNA Methylation Pattern Associated with Pancreatic Cancer
(North Dakota State University, 2021)In this study, we searched for significant hypo and hyper methylation CpG (5'-C-phosphate-G-3') probes from The Cancer Genome Atlas (TCGA) datasets. First, the relationship between hypo and hypermethylation pattern in ... -
Colorectal Cancer: Increasing Awareness of Screening in a Rural North Dakota Community
(North Dakota State University, 2022)Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States, yet only 67% of the eligible population have received screening. Preventative CRC screenings help to reduce mortality and allow CRC ... -
Colorectal Cancer: Utilizing Educational Handouts, Endorsement Letters, and Questionnaires to Increase Screening and Identify Barriers and Facilitators at a Rural Clinic in Elgin, North Dakota
(North Dakota State University, 2020)Introduction: Although colorectal cancer (CRC) is the second leading cause of cancer-related deaths among men and women combined in the United States, only 61% of eligible adults are up-to-date with current screening ... -
Dynamic 3D In Vitro Bone Metastatic Testbeds for Prostate and Breast Cancer
(North Dakota State University, 2022)Metastatic prostate cancer spreads preferentially to the bone, causing skeletal complications associated with significant morbidity and a poor prognosis, despite current therapeutic approaches. Increasing evidence suggests ... -
Label-Free CD8+ T-cell Purification and Electroporation in Relation to CAR T-cell Therapy
(North Dakota State University, 2020)Immunotherapy is becoming recognized as a superior treatment for cancer. In recent years, chimeric antigen receptor (CAR) therapy is among the immunotherapies that has had growing success rates. CAR T-cell therapy takes ... -
A Nano-Sized Approach to Exploiting the Pancreatic Tumor Microenvironment
(North Dakota State University, 2020)Making up just over 3% of all new cancer cases in the United States, pancreatic cancer is not inherently a common malignant disease. Yet, it continuously is shown to be one of the most lethal and common causes of cancer ...